Status:
COMPLETED
Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Osteoarthritis
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The purpose of this study is to use the proteomic analysis of synovial fluid to perform the comprehensive investigation of the biomarker that will be useful to assign the tratment effectiveness of fiv...
Detailed Description
The intra-articular injection with HA is an accepted therapy for OA. However, the exact regulation of HA treatment is unclear. Compared the expression SF proteome from OA patients who received HA/800 ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of osteoarthritis
- Accept the intra-articular HA injection therapy
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01813916
Start Date
May 1 2008
End Date
May 1 2009
Last Update
March 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ccj@Ntu.Edu.Tw
Taipei, Taiwan